e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Macrophages, mononuclear cells and viral infection
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Characterization of M1 and M2 macrophages in human lung tissue
E. Bazzan, G. Turato, E. Mutti, E. Farinazzo, M. Damin, K. Lokar-Oliani, P. Maestrelli, S. Baraldo, M. Saetta, M. G. Cosio (Padova, Italy; Montreal, Canada)
Source:
Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Session:
Macrophages, mononuclear cells and viral infection
Session type:
Thematic Poster Session
Number:
3868
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Bazzan, G. Turato, E. Mutti, E. Farinazzo, M. Damin, K. Lokar-Oliani, P. Maestrelli, S. Baraldo, M. Saetta, M. G. Cosio (Padova, Italy; Montreal, Canada). Characterization of M1 and M2 macrophages in human lung tissue. Eur Respir J 2013; 42: Suppl. 57, 3868
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Increased susceptibility of M2 monocyte-derived macrophages from COPD patients to oxidative stress
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Role of 15-lipoxygenase in the polarization of human lung macrophages
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
COPD monocytes differentiate into pro-inflammatory macrophages regardless of environment
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Identification of Ki67+ ’monocytic’ cells within the lungs
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016
Effect of JQ-1 on monocyte-derived macrophage (MDM) phagocytosis of bacteria and cytokine release
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Impaired monocyte chemotaxis in COPD
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Differential sensitivity of subsets of monocyte-derived macrophages to apoptosis; its impact on lung inflammation
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Oxidative stress drives defective efferocytosis in COPD M2-like macrophages
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Increased expression of sphingosine-1-phosphate and S1PR2 are associated with attenuated macrophage phagocytosis in COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Distinct localization of estrogen receptors in lungs of severe COPD patients
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Elevated GM-CSF in COPD may drive defective macrophage phenotype
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Monocyte-derived macrophages from non-smoker COPD subjects exhibit defective bacterial phagocytosis
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Alveolar type II cells transplantation in pulmonary fibrosis: Effect on the lung macrophage activation
Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Year: 2013
Monocyte sub-populations do not reflect differences in COPD macrophage phenotype
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
IL-33 and TSLP gene expression are increased in response to human rhinovirus 1B in HDM-treated murine bone marrow-derived macrophages
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Biomass smoke particles induce cytokines and reduce phagocytosis by monocyte-derived macrophages
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Phenotypes of alveolar macrophages in normal human lung and their polarization with disease
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
The effect of
in vitro
culture methods on corticosteroid sensitivity in COPD alveolar macrophages
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
MiR-185/AKT and miR-29a/collagen 1a pathways are activated in IPF alveolar macrophages
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Adiponectin acts as an anti-inflammatory cytokine on human lung macrophages
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept